India’s digital neural networks are set to step
into self-regulated, self-taught proliferation zone, led by the second largest
digital consumer base globally (800mn+ internet users), massive government
impetus and keen private innovation. Thus, reportedly, India’s digital economy
is forecasted to snowball into USD 800bn by 2030, growing 2.4x faster than its
economy in FY14-19 (source). And MSMEs, the key brace structure of the economy
with 26%+ GDP contribution in FY22, have sharply stepped digitisation pace.
MSME digital penetration should grow 6x in FY20-25, as per Redseer. Expect plays
such as Indiamart (INMART IN)/Justdial (JUST IN) that offer direct play on MSME
digitisation, to set the pace for such progress and in turn benefit.
MSME business dynamics are seeing a paradigm
shift, led by nuanced policy support and post-Covid recovery. Improving MSME
credit growth, manufacturing revival, supportive government/RBI policies and
rural demand traction enable a prolific seedbed for MSMEs. Moreover, a crest
emerging off of Covid was the fast MSME digital adoption, add to which the Open
Network for Digital Commerce (ONDC) variable may hasten MSME digital adoption.
Agrochemicals demand is likely to remain
buoyant on account of robust growth in world oilseed production (as per USDA).
At the same time ex-agrochemicals demand is likely to remain tepid over the
next couple of months and is likely to recover with increase in global
discretionary spend. The only silver lining for all chemicals players currently
is the continued decline in freight rates and reintroduction of export
incentives from mid-Dec’22. This could help improve margins in both 4QFY23 and
1QFY24.
Agrochemicals demand likely to remain
buoyant: As per US Department of Agriculture (USDA)
reports, world oilseed production in CY23 is likely to grow at a robust 4% YoY;
this level of growth was last seen in CY21 on account of pandemic-led
disruptions. At the same time, IGC expects world grain production to moderate
only a little in CY23 and sees strong growth in CY24. Moreover, in case of
India, oilseed production growth in CY23 is likely to taper to 1.2% vs. ~4-5%
growth over the last 3-4 years. Hence, in our view, agrochemicals demand in the
exports market is likely to remain buoyant while domestic agrochemicals demand
could be flat compared to CY22. This bodes well specifically for contracted
agrochemicals focused players such as Navin, PI, SRF, and Anupam.
Ex-agrochemicals demand weakness to
persist over next couple of months: Basis our channel
checks, demand for non-agrochemicals, especially personal care, flavours and fragrances,
and cleaning chemicals remains weak. As a result, we believe non-agrochemicals
focused players are likely to face challenges in volume off-take in 4QFY23.
In some cases, end-customers have excess
inventories lying idle for these chemicals. In our view, demand recovery for
these chemicals is contingent on inventory drawdowns, which is likely with the
increase in global discretionary spend.
Increase in basic chemicals prices
unlikely to dent margins: Over the last couple
of months, prices of most basic chemicals have risen marginally after falling
20-30% over the last 12 months. In our view, this increase in basic chemicals
prices is unlikely to hinder the margin for a majority of the specialty chemicals
companies under our coverage given that all chemical companies will benefit
from the revised export incentives scheme (~0.8-1.2% across different
chemicals) that came into effect from 16th Dec’22.
Freight rates continue their downward
trajectory: On account of decongestion at major
ports and waning demand, India–North America and India–Europe freight rates
have been on a continuous decline since May’22. In our view, this downward trajectory
is likely to continue as the current freight rates are still 50-60% higher compared
to the stable pre-Covid levels. This decline in freight rates was one of the contributors
for the margin improvement of Indian chemicals players in 3QFY23. We expect
this trend to continue in 4QFY23 as well.
We believe that the Nifty IT’s outperformance
vs the Nifty by ~7ppts since 30th September 2022 till date has largely been
driven by the ‘delayed landing’ narrative that has developed around resilience
of the US economy along with better growth prospects for both Europe as well as
China in 2023 compared to earlier expectations. However, the narrative has
turned very fluid post the problems that have surfaced in the banking sector in
both US as well as Europe in the last fortnight. Early signs of economic stress
are beginning to emerge from the fastest increase in Fed funds rate in recent
history. This in our view will lead to at least our base case of a shallow
recession in the US, if not something worse playing out by 2H2023.
The potential impact of the recent banking
stress in the developed markets has not been incorporated in our estimates,
which broadly remain unchanged since 3QFY23 results season. Our USD revenue
growth estimates for Tier-1 IT companies for FY24 are still in low to
mid-single digits with downside risks while consensus is anticipating high
single-digit growth, implying a belief in the ‘soft/no landing’ narrative. Our
EPS estimates are lower than consensus for FY24/FY25 by 5-10% due to lower
revenue as well as margin estimates.
We are also working with lower target PE
multiples vis-à-vis consensus as we believe that the structural IT industry
growth is not going to be materially higher than where it was pre-pandemic. Our
target PE multiples are not pessimistic as they are 2-3x higher than what the
IT industry had witnessed during the last major downcycle in 2008-2009 and are
at the higher end of the pre-pandemic range.
While many verticals/sub-verticals have come
under pressure over the last nine months, including Mortgage, Hi-tech, Capital
Markets, Healthcare, Retail, P&C Insurance, Telecom, etc, the banking space
in 2022 was generally resilient because of improved NIMs and low credit costs.
However, with deposit costs likely to rise following the SVB episode, most US
banks will see NIMs compress from current expectations. With likely higher
credit costs, profits will be under pressure, leading to constrained spending
on IT. Investment banks could suffer because of lower capital market and
M&A activity in 2023 as was the case in 2022.
We expect somewhat similar pressure for the
large European BFSI institutions. We think that the top 25 western BFSI firms
will form an outsized chunk of the BFSI revenue base of Indian IT companies. Regional
US banks (the hardest hit lately) are likely not big clients for the Indian IT
industry, but their dislocation will likely not bode well for the US economy
and could have an outsized negative indirect impact on IT spend. The S&P
500 Index earnings (including those of components, see Exhibit 5,6)
deteriorated throughout CY22 and are set to worsen further in CY23.
The banking problems in both US as well as
Europe may accentuate the weakness. We think that all these problems could mean
at best a flat tech spending scenario in 2023 (our base case), if not worse.
The Russell 2000 index (US small cap index) internals and the spike in
bankruptcy filings are indicating signs of stress in the broader US economy
(even before the SVB/CS collapse). In FY23, the Indian IT/ITES industry’s
exports are 4x of what they were at the time of GFC and believe the adverse DM
macros will have a larger impact than it did in FY2010 when industry grew by
just mid-single digit rate. We especially are concerned about Tier-2 IT players
where exposure beyond non-Global-500 set is likely larger. PE premium of Tier-2
vs Tier-1 seems unsustainable.
The Jefferies Economic Indicator (JEI)
shows activity slowed in February. The fourth
iteration of our economy tracker composite indicator, the JEI (based on 34
monthly data), shows MoM activity slowed somewhat. The Feb'23 JEI YoY growth is
down 2ppt MoM to 7%, in-line with the 3-mma. The improving / stronger data
points were nearly two-fifths of the group (14).
While Jan month activity JEI helped by a low
base (COVID third wave); February is on a normalized activity base; and notably
better than December.
Broad-based indicators broadly inline
with 3mma. The e-way bill generation for Feb'23
was +18% YoY, -2ppt MoM, but inline with the 3mma. Railway freight traffic
growth at 4% YoY was inline with 3mma while port traffic at 13% YoY was 1ppt
above. Petrol / Diesel consumption growth at 9%/8% YoY was -1ppt each vs. the
3mma. Electricity consumption +8% YoY, was -2ppt vs. the 3mma, partly on
weather effects (early summer).
Urban consumption trends normalizing. Feb'23 urban consumption trends were mixed, impacted by the low
Jan'22 base / pent-up release in Feb'22. Auto registrations for Feb'23 of
2W/PVs were +18%/+10% YoY, +7ppt/-3ppt MoM. Spending at malls was +12% vs.
Feb'20, flat MoM. Credit & debit card spending +20% YoY, was inline with
the 3mma. Property registrations in Mumbai/Delhi declined YoY, but for Jan-Feb
combined were +1%/+37% YoY.
Rural trends somewhat better. The employment demanded under the rural employment guarantee
(NREGS) scheme was -12% YoY and 5% below the pre-COVID levels. Construction
indicators seeing mixed trends with steel consumption (+11% YoY) strong though
Jan cement production (+5% YoY), at a 3-mth low. Housing starts are at a 9 year
high and should help drive construction employment / rural transfer economy.
While winter crop production (wheat expected +4% YoY) is not impacted by early
summer onset, our analysts have raised concerns on a possible drought in 2023.
Trade deficit declines further. Mixed inflation trend. The CPI declined by 0.1ppt to 6.4%, but was
higher than ests and stayed above the RBI's 6% upper limit. WPI declined by
0.9ppt to a 25-mth low of 3.9%, a relief. Indeed, lower WPI is now reflecting
(link) in slowing bank credit growth which at 15.5% is 2.4ppt below Oct'22
peak.
Feb trade data saw the second consecutive month
of decline in trade deficit, which at US$17bn was -7% YoY. Exports continued
their decline for the 3rd month, with the Non-oil exports -4% YoY. The domestic
demand linked imports (ex-oil, ex-Gold) were -4% YoY. Despite lower goods
deficit and sharp rising services net surplus (US$15bn, +76% YoY); FX reserves
were -US$15bn. Import cover is comfortable at 9.4-months.
Almost all Pharmaceuticals companies in our
coverage universe are trading at deep discounts (average ~25% discount) vs the
historical 5-year average forward multiples - even excluding Covid-19 period
valuations.
FY23 has been a challenging year for the sector
owing to slowdown in overall growth, margin contraction and enhanced regulatory
concerns. Domestic growth has been impacted by a higher covid base while US
generics business has been impacted by double-digit price erosion. Margins have
also contracted due to US price erosion, elevated cost inflation and a higher
covid base. Apart from these headwinds, enhanced regulatory concerns, which were
absent during the covid period, have also resurfaced, affecting sentiment for
the sector. As the base normalises, we believe that domestic growth is expected
to be back in double digits in FY24 while price erosion in the US is expected
to cool off from double-digit levels to single digit levels. On the margin
front, cost inflation is normalizing, and companies have to a great extent
passed on the burden of additional costs, largely in branded markets. On the
flip side, we believe that the USFDA inspections are still on the lower side
(330 in CY19 against 77 in CY22), but the same are expected to increase from
here on. Hence, our focus remains on companies that are heavy on branded
generics and have the least exposure to US generics.
We also expect mean reversion in brand-centric
/heavy companies with recovery in growth amid margin improvement.
Notwithstanding the hype behind the high growth
western Quick Service Restaurant category, we believe companies in this space
will still be valued based on their margin strategy. Our in-depth study delves
into the strategies of both i.e., the Indian companies and their global parents
to understand how they are evolving and shape-shifting to win in the Indian
market. We give little credence (though not ignored) to beaten to a pulp words
like convenience, efficiencies, digital devices, disposable incomes, etc. as
they disconcert you enough to believe the woods for the forest. Hence, instead
look at margins and volumes, these will define the future prospects as the
companies expand out of saturated metro and tier-1 markets, because they are
still consumer companies!
Western QSRs to outperform as
international brands perfect product basket right: Our in-depth study reveals the strategies followed by global
parent i.e. (1) follow margin expansion in the developed markets, (2) while
drive the store expansion in emerging markets due to expanding QSR market
opportunity and penetration beyond metros. Further, while store growth is
important, margins and volumes will define the future prospects as companies
expand out of saturated metro and tier-1 markets. Our study pointed three
significant developments in consumption, (1) consumer affinity towards western
QSRs, (2) changing consumer habits – simplicity of ordering and delivery
through time efficient digital platforms, and (3) easing of competition from
local outfits. Though millennials are shaping up demand favouring the shift
towards organised segment, QSRs have used recent crisis to optimise cost
structures, and they are capturing market share.
Surge in QSR network to drive revenue: CAGR of 13% over FY20-25E We expect India’s organised food
services market to grow at CAGR of ~10.5% to Rs1,684bn over FY20-25E capturing
~46% market share from current 40%. Given vast growth potential, organised
segment chains to grow at 13% CAGR garnering 12% market share of food service
market to Rs383bn. Industry estimates point out Informal Eating out (IEO)
market at Rs3.2trn and expecting to grow CAGR 12% in next 5 years. Growth in
total addressable market (TAM) to be driven by, (1) targeting millennials, (2)
consumer centric palate and choices, (3) focusing on online, time efficient
delivery models, and (4) strategic pricing and promotions offering value proposition.
Further, established brand acceptance helped top-5 global QSRs to garner ~50%
market share with high concentration in top 25 cities, nonetheless, the brand
reputation helps smoother entry in Tier 2/3 markets providing huge runway for
growth. Therefore, we believe top QSR players to add +2,000 stores over
FY22-25E.
Central government capex (ex-highways) for
FYTD23 is up 14% y-y led largely by railways (+54% y-y), and by drinking water
(+19% y-y) offset by weakness in defence (down 1% y-y).
Ex-railways capex growth was modest at ~3% y-y (we are not considering road
capex as FY23 is entirely budget funded, while FY22 included significant extra
budget funding). We note that road construction has been weaker
against corresponding periods in FY22 and FY21.
Pace of state capex lower, whereas cumulative capex increased 3.8% y-y . FYTD23 (until Jan)
capex for 12 key states (70% of aggregate state capex) fell to 46.4% of
budgeted spending (vs 53.3% for FYTD22). However, given elevated levels of
inflation, the y-y increase in capex would be lower in real terms, in our
assessment.
Indian financials have also borne rub-off
effect of global dislocations. They are better placed with higher share of
retail deposit, limited ALM gap & MTM, limited dependence on AT-1 bonds
& lower exposure to riskier segments like promoter/ acquisition finance.
While equities & global bonds saw pressure off late, local bond mkt is
stable. Post correction, vals of some
are near/below Covid lows
Higher share of retail deposits and lower
ALM gaps. The deposit profile of Indian banks is
highly dependent on household/ retail deposits that form >60% of total
sector deposits. Banks have also been increasing focus on this segment to
granularise deposits. ALM gaps, as measured by share of <1yr liabilities vs.
share of <1yr assets, are also limited. Even NBFCs have been watching this
aspect much more closely post the debacle of IL&FS few years before Covid.
Interestingly on the bond side, while the prices of overseas bonds (issued by
Indian issuers) have seen correction our conversation with local bond experts/
corporates indicate that local market is fairly stable and price action will be
function of rate actions.
AT-1 bond market has polarised towards
large/ quality banks post Yes Bank. India had a
Credit Suisse like AT-1 bond issue right around Covid when Yes Bank wrote-down
AT-1 bonds and still there was some franchise value assigned to equity through capital
infusion by leading banks/ NBFC. Since then, the issuances have been lower and
market has become polarized towards larger/ quality banks. Among banks, top-3
issuers are SBI, HDFC Bank and Canara Bank with PSU banks having higher
contribution from this. Interestingly, smaller banks have a lower contribution
from AT-1 bonds. Local bond mkt investors aren't really seeing risks here for
Indian stocks.
Lower risk from MTM and asset quality. As discussed in our recent note, The SVB Test On Indian Banks:
Sector Holds-Up, Again!, on assets side of banks, loans form 65% &
investments 25%. HTM is allowed on GSecs & forms 80% of that & 15% of
assets. On 4-5yr duration, impact will be just 6% of capital for Pvt. BKs &
15% for PSUs. Asset quality trends were strong, with slippages during 3QFY23 at
multiyear low of 1.6% & recoveries from past NPLs helping to keep credit
costs low at 1% of avg. loans.
Valuations in some cases below Covid
lows. While the global events, especially in
the financial sector, have stirred confidence and increased COE, we also note
that valuation of Indian banks is looking fairly attractive and in some cases
stocks trade below the levels during the height of Covid risk. Stocks above
US$5bn in mkt cap that are trading below the Covid-low valuations are Kotak
Bank, IPru Life, ICICIGI and HDFC Life. Life insurers are also attractive (and
below Covid lows) but clarity on taxation of insurance policies will be key to
rerating.